Head-To-Head Analysis: Check-Cap (NASDAQ:MBAI) and Nanovibronix (NASDAQ:FEED)

Check-Cap (NASDAQ:MBAI) and Nanovibronix (NASDAQ:FEED) are both small-cap manufacturing companies, but which is the better business? We will compare the two businesses based on the strength of their risk, profitability, earnings, dividends, institutional ownership, analyst recommendations and valuation.

Analyst Ratings

This is a breakdown of recent ratings for Check-Cap and Nanovibronix, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Check-Cap	1	0	0	0	1.00
Nanovibronix	1	0	0	0	1.00

Volatility and Risk

Check-Cap has a beta of 0.72, meaning that its share price is 28% less volatile than the S&P 500. Comparatively, Nanovibronix has a beta of 2.21, meaning that its share price is 121% more volatile than the S&P 500.

Profitability

This table compares Check-Cap and Nanovibronix’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Check-Cap	N/A	N/A	N/A
Nanovibronix	-275.12%	-24.78%	-19.24%

Insider and Institutional Ownership

1.1% of Check-Cap shares are owned by institutional investors. Comparatively, 16.4% of Nanovibronix shares are owned by institutional investors. 0.5% of Check-Cap shares are owned by company insiders. Comparatively, 1.4% of Nanovibronix shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Valuation and Earnings

This table compares Check-Cap and Nanovibronix”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Check-Cap	N/A	N/A	-$25.15 million	($2.77)	-0.59
Nanovibronix	$2.56 million	0.96	-$3.70 million	($41.74)	-0.05

Nanovibronix has higher revenue and earnings than Check-Cap. Check-Cap is trading at a lower price-to-earnings ratio than Nanovibronix, indicating that it is currently the more affordable of the two stocks.

Summary

Nanovibronix beats Check-Cap on 6 of the 10 factors compared between the two stocks.

About Check-Cap

Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient’s back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation. The company was incorporated in 2004 and is based in Isfiya, Israel.

About Nanovibronix

NanoVibronix Inc. is a medical device company that is focused on creating medical products utilizing its proprietary low-intensity, surface acoustic wave technology. … NanoVibronix’ catheter-based products include the UroShield™ and NG-Shield™ devices that are both CE mark certified.